Response-adapted consolidation therapy strategy for patients with metastatic high-risk neuroblastoma: Results of the SMC NB-2014 study.
Eun Seop SeoJi Won LeeHee Won ChoHee Young JuYoung Seok ChoSanghoon LeeSeung Hwan MoonKeon Hee YooDo Hoon LimKi Woong SungPublished in: Pediatric blood & cancer (2024)
Our results suggest that response-adaptive consolidation therapy based on chemotherapy response at metastatic sites facilitates better treatment tailoring, and appears promising for patients with metastatic high-risk neuroblastoma.